SAPPHIRE: Phase III Study of Sitravatinib Plus Nivolumab Versus Docetaxel in Advanced Nonsquamous Non-Small-cell Lung Cancer.

H. Borghaei,F. de Marinis,D. Dumoulin, C. Reynolds,W. S. M. E. Theelen,I. Percent,V. Gutierrez Calderon,M. L. Johnson, A. Madroszyk-Flandin,E. B. Garon,K. He,D. Planchard,M. Reck,S. Popat,R. S. Herbst,T. A. Leal, R. L. Shazer,X. Yan, R. Harrigan, S. Peters

ANNALS OF ONCOLOGY（2024）

引用 0|浏览51

暂无评分

关键词

sitravatinib,nivolumab,NSCLC

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要